GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aethlon Medical Inc (NAS:AEMD) » Definitions » Cyclically Adjusted PB Ratio

AEMD (Aethlon Medical) Cyclically Adjusted PB Ratio : 0.02 (As of May. 28, 2025)


View and export this data going back to 1999. Start your Free Trial

What is Aethlon Medical Cyclically Adjusted PB Ratio?

As of today (2025-05-28), Aethlon Medical's current share price is $0.3699. Aethlon Medical's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was $21.32. Aethlon Medical's Cyclically Adjusted PB Ratio for today is 0.02.

The historical rank and industry rank for Aethlon Medical's Cyclically Adjusted PB Ratio or its related term are showing as below:

AEMD' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.02
Current: 0.02

During the past years, Aethlon Medical's highest Cyclically Adjusted PB Ratio was 0.02. The lowest was 0.00. And the median was 0.00.

AEMD's Cyclically Adjusted PB Ratio is ranked better than
98.19% of 496 companies
in the Medical Devices & Instruments industry
Industry Median: 1.825 vs AEMD: 0.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Aethlon Medical's adjusted book value per share data for the three months ended in Dec. 2024 was $0.310. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $21.32 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Aethlon Medical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Aethlon Medical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aethlon Medical Cyclically Adjusted PB Ratio Chart

Aethlon Medical Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.11

Aethlon Medical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.11 0.03 0.02 0.04

Competitive Comparison of Aethlon Medical's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Aethlon Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aethlon Medical's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aethlon Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Aethlon Medical's Cyclically Adjusted PB Ratio falls into.


;
;

Aethlon Medical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Aethlon Medical's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.3699/21.32
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aethlon Medical's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Aethlon Medical's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book=Book Value per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.31/133.1571*133.1571
=0.310

Current CPI (Dec. 2024) = 133.1571.

Aethlon Medical Quarterly Data

Book Value per Share CPI Adj_Book
201503 13.977 99.621 18.682
201506 99.510 100.684 131.605
201509 76.490 100.392 101.455
201512 53.922 99.792 71.950
201603 30.451 100.470 40.358
201606 8.490 101.688 11.117
201609 -1.333 101.861 -1.743
201612 1.442 101.863 1.885
201703 11.458 102.862 14.833
201706 -14.661 103.349 -18.890
201709 1.703 104.136 2.178
201712 46.049 104.011 58.953
201803 51.983 105.290 65.742
201806 44.220 106.317 55.384
201809 34.689 106.507 43.369
201812 26.548 105.998 33.350
201903 19.094 107.251 23.706
201906 9.016 108.070 11.109
201909 1.112 108.329 1.367
201912 8.230 108.420 10.108
202003 10.043 108.902 12.280
202006 12.693 108.767 15.539
202009 11.332 109.815 13.741
202012 9.545 109.897 11.565
202103 7.762 111.754 9.249
202106 16.162 114.631 18.774
202109 14.960 115.734 17.212
202112 13.433 117.630 15.206
202203 11.111 121.301 12.197
202206 9.420 125.017 10.033
202209 8.657 125.227 9.205
202212 7.522 125.222 7.999
202303 6.552 127.348 6.851
202306 5.277 128.729 5.459
202309 4.139 129.860 4.244
202312 2.931 129.419 3.016
202403 2.192 131.776 2.215
202406 0.625 132.554 0.628
202409 0.431 133.029 0.431
202412 0.310 133.157 0.310

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Aethlon Medical  (NAS:AEMD) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Aethlon Medical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Aethlon Medical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aethlon Medical Business Description

Traded in Other Exchanges
N/A
Address
11555 Sorrento Valley Road, Suite 203, San Diego, CA, USA, 92121
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
Executives
Nicolas Gikakis director 11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO CA 92121
Lee D Arnold officer: Chief Scientific Officer C/O ASSEMBLY BIOSCIENCES, INC., 99 HUDSON STREET, 5TH FLOOR, NEW YORK NY 10013
Angela Rossetti director PALATIN TECHNOLOGIES, INC., 4B CEDAR BROOK DRIVE, CRANBURY NJ 08512
Steven P Larosa officer: Chief Medical Officer 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA 92123
Chetan Shah director 9 GRACE HILL COURT, TITUSVILLE NJ 08560
Fisher Charles J Jr director C/O AETHLON MEDICAL, INC., 9635 GRANITE RIDGE DR., SUITE 100, SAN DIEGO CA 92123
Guy F. Cipriani director 1727 EAGLERIDGE DRIVE, BELLINGHAM WA 98226
Sabrina Martucci Johnson director 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
Rodell Timothy C Jr officer: Interim CEO 201 MIDLAND AVE, ASPEN CO 81611
Weiner Family Revocable Trust Ellen R. 10 percent owner 10645 N. TATUM BOULEVARD, SUITE 200-166, PHOENIX AZ 85028
Phillip A Ward director 8910 UNIVERSITY CENTER LANE #660, SAN DIEGO CA 92122
Thomas V Wornham director 8910 UNIVERSITY CENTER LANE #660, SAN DIEGO CA 92122
Rodney S Kenley director, officer: President 9635 GRANITE RIDGE DRIVE, SUITE 100, SAN DIEGO CA 92123
James B Frakes officer: Chief Financial Officer 9635 GRANITE RIDGE DRIVE, SUITE 100, SAN DIEGO CA 92123
Barry Franklyn S Jr director 1141 DELAWARE AVENUE #3N, BUFFALO NY 14209